Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I thought it was strictly about the NCE.
And is it working days or calendar days?
So do we know what day it was submitted?
Yep a good rule of thumb, can have up to 3 days to catch its breath when trending.
Well based on the trading action, there is no fear that the FDA is going to be taken down tomorrow. Hope Buffalo Bill is right because it will be a hell of a squeeze because the shorts are most definitely present.
#AMRNSELLLIMIT30 ...... Like the sound of that.:)))
Anyone know the time of the hearing on Tuesday? Sorry if it was already stated. Thx
Exactly.
2 thumbs up!
Squishier?
"No, the world is a very unhealthy place my friend, diets suck, sitting on their butts web surfing, reading messages boards".....well stated.
What does history tell you of the chances of that happening? Thanks "Halting the trial will depend on how active and perceptive the ethic committee is. They should unblind the trial and continue it with everyone taking Vascepa.."
60 Minutes
I've enjoyed for the most part reading the board and learning the lay of the land so to speak of the company. I'll say it again, if the argument is such a slam dunk in exposing wrongs in the system and how it is costing lives (or quality of lives); 60 Minutes would love to sink their teeth into it. Being an older businessman, I do believe in working smarter, not harder because it does seem a great deal of effort has been exerted. I don't understand why that avenue is not seriously considered, not just talked about. It appears to me you have more than enough ammo. On the other hand, if you're not really sure that V is quite everything you think, then I can understand why you wouldn't approach them. But everyone is different..... Good luck to us. It seems to me there are some people here that could reach out to find the right contacts to get the ball rolling.
That would be great but first things first. Next up is 3/17 correct?
5-7 years from now?
So do you feel after the 17th we'll have a much clearer picture re: FDA and us?
AAHHHH. Final sentence, thanks!
I want a piece of that action. :)
Re: AMR 102, what is the status of it? Digging thru pr's, the last thing I see is the PR dated 7/21/13 from the co. And I can't seem to find it at Clinicaltrials.gov. Was it pushed to the side temporarily because of cash flow? tia
It'll be fine. They did it for the right reasons. Just went thru this with another of mine; Curis-CRIS offering was @ 2.75. Note date of it and price action since.
Good post.
The other thing brought up as I read everything here is the Obamacare angle\generics. Talk about a hot button that may grab their attention!
Just throwing it out there, what about 60 Minutes? With everything I've read here, I'd think this is right up their alley.
Agreed. Pretty typical of most bios; earnings secondary except for that temp knee jerk reaction. It's about all the other items.
Thank you.
When would we know what was discussed today?
Thanks for that SA link. A must read for new investors\great overview of the current dynamics.
Thanks for the reply. Sorry to probably ask some obvious questions as again I'm trying to get up to speed with my recent investment, is there something important that is going to definitely happen in D.C. this month that has implications for us? tia
I've really enjoyed the education on the background of the companys' challenges in the recent past. I am a pretty basic person. That being said the various thoughts here being entertained, wouldn't they have also been entertained by the company and acted upon if they are all facts? Just wondering. If there have been all these blatant things done (not saying otherwise) by the FDA, wouldn't there be a politician and lawyer out there somewhere that would just love to ride this to huge notoriety and make things "right"?
So you make the comment, "REDUCE-IT changes nothing under these circumstances, the FDA wants to give REDUCEIT to the 8 Generic filers and you must act now to stop them. WE MUST GET THIS INFO TO CONGRESS, PRIOR TO THIS TUESDAY HOUSE MEETING." Sorry if I missed an earlier discussion pertaining to this but is the company doing exactly what you say must be done? tia
The key now is get the distribution of the new shares behind us and the presentations in the next 2 weeks hopefully give further updates on how the 907 expansions are progressing. Then off the top of my head, we wait for Q1 results and updates; and then ASCO. During that time I expect a methodical rise in PPS in expectations of very good news at ASCO. Pretty cut and dry. One wildcard during that time I'd like to see happen is that Roche resumes the IPF\Erivedge trial. That could be very large for us down the road. Very big population. For the T/A inclined people there are obvious resistance areas along the way. We briefly touched the one premarket- the 3.60 area the other day; then the gap to fill @ 3.85; and then another in the 4.4-4.6 area.
Thanks for your reply and thoughts!
Could you give an educated conservative time frame when you say, "We should have a ruling on the NCE nonsense soon and hopefully we will get clarification on the ANCHOR sNDA soon after." Thank you.
The Naz site, not always up to date, shows 30%. Have a link to your source?
Fine.
No problem. I unfortunately expect the falsehoods to increase.
Yes it is a very dangerous chart to short for sure!
He is a bitter ex-long that sold at the bottom. I saw his post. He also unfortunately achieved his desired results with you - putting seeds of doubts in your mind. So he does know the company to a degree. Please don't take it personal. Imagine the seeds of doubt I've had being a stockholder and adding over the years since late 2011. I chuckled when I saw his post regarding a r/s. A secondary, they have said they have money to mid 2016. With these additional P1's that will fire up from the recently announced joint venture, I believe you can use your common sense that they will have to raise additional monies at some point. Last I looked you have to spend it to make it. Personally I don't have a problem with it if you're executing your business plan being a 26 year business owner. If you've been around you know many secondaries are gobbled right up when the story is good. As I said in the previous post, I feel in the next 45 days there will be continuing increased visibility how things are progressing. Also as I said previously I want that IPF trial to resume and that is out of their hands. It had just begun when Roche halted it to rework the trial. I'd like to think by midyear at the latest. And it wouldn't hurt to hear the royalty rate for Erivedge went up a 1/2% or 1% now that it hit $140M in annual sales. :) The best laugh I had this weekend was an obvious short at Twitter that reached out to Jim Cramer about Curis. :)))
Also just a few other things upcoming in the next ~45 days. In addition to their CC later this month they typically present\tell their story at RBC's, Cowen's, and Roth's conferences-all happening in the immediate future if they do this year-not announced yet-typically a week in advance. And then at the end of March there will be serious re balancing of funds I'd think that they would be absorbed into, imo. Could be very exciting times these next 45 days or so.